Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin: facts and new hypotheses.

B Risberg1

  • 1Department of Vascular Surgery, Sahlgrenska University Hospital, Göteborg University, Sweden. bo.risberg@surgery.gu.se

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|April 2, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-localization of fibrinolytic activators and inhibitors with macrophages in atherosclerotic vessels.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.

British journal of cancer·2014
Same author

Flotillins as regulators of ErbB2 levels in breast cancer.

Oncogene·2012
Same author

Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions.

Cytopathology : official journal of the British Society for Clinical Cytology·2011
Same author

Measurement of apoptosis in cytological specimens by flow cytometry: comparison of Annexin V, caspase cleavage and dUTP incorporation assays.

Cytopathology : official journal of the British Society for Clinical Cytology·2010
Same author

Effect of varicose vein surgery on venous reflux scoring and plethysmographic assessment of venous function.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2008
Same journal

Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
See all related articles

Antithrombin (AT) deficiency is common in critical illness and linked to poor outcomes. Emerging research suggests AT has anti-inflammatory effects beyond coagulation, offering new therapeutic possibilities.

Area of Science:

  • Biochemistry
  • Hematology
  • Critical Care Medicine

Background:

  • Antithrombin (AT) is a key inhibitor in the coagulation cascade, significantly enhanced by heparin.
  • AT deficiency arises from hereditary disorders or acquired conditions like sepsis, trauma, and surgery, often leading to disseminated intravascular coagulation (DIC).
  • Low AT levels in critical illness correlate with poor prognosis and multiple organ failure, despite AT supplementation not significantly improving survival.

Purpose of the Study:

  • To explore the non-coagulation-dependent effects of Antithrombin (AT).
  • To investigate the potential anti-inflammatory actions of AT.
  • To understand AT's role in preventing vascular hyperplastic responses.

Main Methods:

  • Review of existing literature on Antithrombin (AT) function.

Related Experiment Videos

  • Analysis of cell culture and animal experiment data.
  • Examination of AT's interaction with cell membrane glycosaminoglycans.

    • Main Results:

    • Antithrombin (AT) promotes endothelial prostacyclin production, indicating anti-inflammatory properties independent of heparin.
    • AT interacts with cell membrane glycosaminoglycans to exert these effects.
    • AT's role in vessel wall antithrombogenicity and potential in preventing post-traumatic hyperplastic responses is increasingly recognized.

    Conclusions:

    • Antithrombin (AT) possesses anti-inflammatory actions mediated by endothelial prostacyclin production.
    • These effects are independent of AT's anticoagulant activity and heparin.
    • AT may play a significant role in managing inflammatory responses and preventing vascular hyperplasia post-injury.